Skip to main content
Immuron Ltd logo

Immuron Ltd — Investor Relations & Filings

Ticker · IMRN ISIN · US45254U1016 LEI · 529900ZIDI5C9C9TTI91 ASX Manufacturing
Filings indexed 1,600 across all filing types
Latest filing 2026-04-16 Earnings Release
Country AU Australia
Listing ASX IMRN

About Immuron Ltd

https://www.immuron.com.au

Immuron Ltd. is a clinical and commercial-stage biopharmaceutical company focused on developing and commercializing a novel class of orally delivered, specifically targeted polyclonal antibodies. The company's proprietary technology platform is based on polyclonal immunoglobulins (IgG) derived from hyper-immune bovine colostrum to address unmet medical needs, primarily related to gastrointestinal and enteric diseases. Its commercialized products include Travelan®, for reducing the risk of travelers' diarrhea, Protectyn®, for supporting gut and liver function, and ProIBS®, for relieving symptoms of Irritable Bowel Syndrome. Immuron's clinical pipeline includes therapeutic candidates for infectious diseases such as Clostridioides Difficile and Vancomycin-Resistant Enterococci.

Recent filings

Filing Released Lang Actions
Immuron Double Digit 3Q Sales Growth 3 pages 439.6KB
Earnings Release Classification · 1% confidence The document is an ASX/NASDAQ announcement summarizing Q3 sales results (unaudited) and year-to-date figures, providing highlights and forward-looking statements typical of an earnings press release. There are no full financial statements or management discussion of detailed line items as in an interim report. This aligns with the definition of an Earnings Release (ER). 9M 2026
2026-04-16 English
6-K - Immuron Ltd (0001660046) (Filer)
Foreign Filer Report
2026-04-13 English
Small Holding Share Sale Facility 9 pages 470.2KB
Regulatory Filings
2026-04-12 English
Notification of cessation of securities - IMC 4 pages 14.8KB
Regulatory Filings
2026-03-10 English
Presentation to Coffee Microcaps Conference 16 pages 3.0MB
Regulatory Filings
2026-03-04 English
Change in substantial holding 5 pages 325.3KB
Regulatory Filings
2026-02-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.